{"result": {"id": "06f903d2-6fae-4e39-9de7-7cacde63a692", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "I notice the text is primarily about pharmaceutical drugs and their interactions, which doesn't clearly fit the requested entity types (organization, person, geo, event). The previous extraction attempted to classify drugs as \"organizations\" which was incorrect.\n\nSince there are no clear instances of:\n- Organizations (companies, institutions)\n- People (named individuals)\n- Geographic locations\n- Events (specific occurrences)\n\nAnd all the content is about drug mechanisms and interactions (which would better fit a \"drug\" or \"medication\" entity type that wasn't specified), I cannot properly extract any entities that match the requested types.\n\nThe correct output in this case would be:\n\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1752166522, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 137, "prompt_tokens": 3413, "total_tokens": 3550, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 3328}, "prompt_cache_hit_tokens": 3328, "prompt_cache_miss_tokens": 85}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: �功能不全患者，在接 受含碘对比剂检查 48 h 前停用二 甲双胍。 已接受含碘 对比剂检查的患者，建议在造影完成至少 48 h 后检测 肾功能情况，如果没有恶化即可恢复二甲双胍的服用。\n4.1.2    α- 糖苷酶抑制剂  伏格列波糖在胃肠道内几乎 不吸收入血，不经肝肾代谢，主要以原型经肠道排泄， 无药动学相关的药物相互作用［11］。\n　　　阿卡波糖原型药物在肠道内极少〔 口服生物利用度 （AUC ）为 1%~2%〕被吸收，其在肠道内的代谢产物 35% 吸收入血［12-13］。有报道显示，服用阿卡波糖后发 生的腹泻可减少地高辛的吸收，AUC 减少，血药峰浓 度（Cmax ）显著降低，达峰时间（tmax ）可延长。阿卡波 糖与华法林合用，凝血酶原国际标准化比值（INR ）升高， 出血风险增加，需要及时调整剂量［14-16］。阿卡波糖与 考来烯胺等肠道吸附剂或消化酶类制剂同时合用可能影 响其疗效，临床应避免同时服用。\n4.1.3    磺脲类  我国上市的磺脲类药物主要有格列本  脲、格列美脲、格列齐特、格列吡嗪和格列喹酮。磺脲  类药物在体内主要经 CYP2C9 代谢。合并使用 CYP2C9   抑制剂（如氟康唑、胺碘酮）可能减慢其代谢，增加低  血糖风险。合用 CYP2C9 诱导剂（如卡马西平、利福平、 苯巴比妥）可能加快磺脲类药物代谢，导致血糖升高。\n4.1.4    格列奈类  目前临床应用的主要有瑞格列奈、那\n\n\n格列奈和米格列奈。瑞格列奈经 CYP2C8 和 CYP3A4 代 谢；那格列奈主要经 CYP2C9 和 CYP3A4 代谢；米格列 奈直接经Ⅱ相代谢酶UGT 代谢，极少量经CYP2C9 代谢。 氯吡格雷的代谢产物能够显著抑制 CYP2C8 ，导致瑞格 列奈血药浓度升高 3.9~5.1 倍，显著增加严重低血糖风 险，临床应该避免合用。\n4.1.5    二肽基肽酶Ⅳ（DPP-4 ）抑制剂  沙格列汀主要  通过 CYP3A4/5 代谢，与 CYP3A4/5 强抑制剂（如酮康唑、 阿扎那韦、克拉霉素、茚地那韦、伊曲康唑、奈非那韦、 利托那韦、沙奎那韦和泰利霉素）合用时，能显著升高 沙格列汀血药浓度，合用时沙格列汀的 日剂量不超过 2.5 mg。而沙格列汀与卡马西平（CYP3A4/5 诱导剂 ） 合用时，可通过加\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>二甲双胍<|>organization<|>二甲双胍是一种用于治疗糖尿病的药物，需要在接受含碘对比剂检查前48小时停用，并在检查后48小时检测肾功能后恢复使用)\n##\n(\"entity\"<|>伏格列波糖<|>organization<|>伏格列波糖是一种α-糖苷酶抑制剂，几乎不吸收入血，不经肝肾代谢，主要以原型经肠道排泄)\n##\n(\"entity\"<|>阿卡波糖<|>organization<|>阿卡波糖是一种α-糖苷酶抑制剂，原型药物在肠道内极少被吸收，其代谢产物35%吸收入血，可能与地高辛和华法林等药物产生相互作用)\n##\n(\"entity\"<|>格列本脲<|>organization<|>格列本脲是一种磺脲类药物，主要经CYP2C9代谢，与CYP2C9抑制剂或诱导剂合用可能影响其代谢)\n##\n(\"entity\"<|>格列美脲<|>organization<|>格列美脲是一种磺脲类药物，主要经CYP2C9代谢，与CYP2C9抑制剂或诱导剂合用可能影响其代谢)\n##\n(\"entity\"<|>格列齐特<|>organization<|>格列齐特是一种磺脲类药物，主要经CYP2C9代谢，与CYP2C9抑制剂或诱导剂合用可能影响其代谢)\n##\n(\"entity\"<|>格列吡嗪<|>organization<|>格列吡嗪是一种磺脲类药物，主要经CYP2C9代谢，与CYP2C9抑制剂或诱导剂合用可能影响其代谢)\n##\n(\"entity\"<|>格列喹酮<|>organization<|>格列喹酮是一种磺脲类药物，主要经CYP2C9代谢，与CYP2C9抑制剂或诱导剂合用可能影响其代谢)\n##\n(\"entity\"<|>瑞格列奈<|>organization<|>瑞格列奈是一种格列奈类药物，经CYP2C8和CYP3A4代谢，与氯吡格雷合用可能增加低血糖风险)\n##\n(\"entity\"<|>那格列奈<|>organization<|>那格列奈是一种格列奈类药物，主要经CYP2C9和CYP3A4代谢)\n##\n(\"entity\"<|>米格列奈<|>organization<|>米格列奈是一种格列奈类药物，直接经Ⅱ相代谢酶UGT代谢，极少量经CYP2C9代谢)\n##\n(\"entity\"<|>沙格列汀<|>organization<|>沙格列汀是一种DPP-4抑制剂，主要通过CYP3A4/5代谢，与CYP3A4/5强抑制剂或诱导剂合用可能影响其血药浓度)\n##\n(\"relationship\"<|>二甲双胍<|>含碘对比剂<|>二甲双胍需要在接受含碘对比剂检查前48小时停用<|>8)\n##\n(\"relationship\"<|>阿卡波糖<|>地高辛<|>阿卡波糖可能减少地高辛的吸收<|>6)\n##\n(\"relationship\"<|>阿卡波糖<|>华法林<|>阿卡波糖与华法林合用可能增加出血风险<|>7)\n##\n(\"relationship\"<|>瑞格列奈<|>氯吡格雷<|>氯吡格雷可能显著增加瑞格列奈的血药浓度，增加低血糖风险<|>9)\n##\n(\"relationship\"<|>沙格列汀<|>CYP3A4/5强抑制剂<|>沙格列汀与CYP3A4/5强抑制剂合用可能显著升高其血药浓度<|>8)\n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_e591523348826c004ca540695de3d5384ee7010242d6a68f5b04bc2dc4edc963_v2"}